Who is sponsoring NCT03108612?

NCT03108612 is sponsored by Medwave Estudios Limitada.

What drugs are being tested in NCT03108612?

Interventions in NCT03108612: Análisis de carga de trabajo (ACT).

What condition does NCT03108612 study?

NCT03108612 studies Musculoskeletal Disease, Occupational Exposure.

Is NCT03108612 still recruiting?

NCT03108612 is currently status unknown. Last updated 22 March 2018.

Last reviewed 2018-03-22 · How we verify

NCT03108612: ACT-ACHS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnostic Value of Workload Analysis Instrument to Detect Occupational Risks of Upper Limb Musculoskeletal Conditions

Status unknown NA Last updated 22 March 2018

What this trial tests

NA trial testing Análisis de carga de trabajo (ACT) in Musculoskeletal Disease in 900 participants. Status unknown.

Timeline

9 August 2017

Primary endpoint
30 April 2018

31 August 2018

Quick facts

Lead sponsor	Medwave Estudios Limitada
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	900
Start date	9 August 2017
Primary completion	30 April 2018
Estimated completion	31 August 2018
Sites	1 location across Chile

Drugs / interventions tested

Análisis de carga de trabajo (ACT)

Conditions studied

Musculoskeletal Disease — all drugs for Musculoskeletal Disease →
Occupational Exposure — all drugs for Occupational Exposure →

Sponsor

Medwave Estudios Limitada

Who can join

Adults 18 to 65, any sex, with Musculoskeletal Disease or Occupational Exposure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate the diagnostic accuracy of an instrument (semi-structured interview) called Workload Analysis Instrument (WAI) (Análisis de Carga de Trabajo ACT), in detecting the presence of occupational risk in patients presenting an upper-limb musculoskeletal disorder. The test instrument was developed by Asociación Chilena de Seguridad (ACHS). This instrument will be applied to the worker when he or she visits the ACHS health care facility. The test administration is performed by an ergonomics specialist previously trained in WAI. WAI is the index test and the gold standard will be the Estudio de Puesto de Trabajo (EPT) resolution. The hypothesis of the study is that WAI is able to correctly label the occupational origin (rule in or rule out) of an upper-limb musculoskeletal disorder. Sensitivity, specificity and positive predictive value will be established.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Musculoskeletal Disease

Currently open trials in the same condition.

NCT06747052 — Gender Impact On Physical Activity In Chronic Musculoskeletal Disorders Prevention · recruiting
NCT07261553 — Adherence to Home-Based Exercises in Musculoskeletal Disorders · recruiting
NCT04037735 — RSA-RCT: Attune S+ TKA Versus Sigma TKA · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03108612 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medwave Estudios Limitada
Last refreshed: 22 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03108612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing